Form 8-K - Current report:
SEC Accession No. 0001213900-24-102170
Filing Date
2024-11-25
Accepted
2024-11-25 16:15:08
Documents
13
Period of Report
2024-11-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222389-8k_cormedix.htm   iXBRL 8-K 38773
  Complete submission text file 0001213900-24-102170.txt   213962

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crmd-20241121.xsd EX-101.SCH 3015
3 XBRL LABEL FILE crmd-20241121_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE crmd-20241121_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0222389-8k_cormedix_htm.xml XML 3671
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 241496089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)